Secondary antibody-induced treatment failure under therapy with incobotulinumtoxinA (Xeomin®) in a patient with segmental dystonia pretreated with abobotulinumtoxinA (Dysport®)

被引：4

作者：

Kamm, Christoph ^{[1
]}

Schuemann, Friederike ^{[1
]}

Mix, Eilhard ^{[1
]}

Benecke, Reiner ^{[1
]}

机构：

[1] Univ Rostock, Dept Neurol, D-18147 Rostock, Germany

来源：

JOURNAL OF THE NEUROLOGICAL SCIENCES | 2015年 / 350卷 / 1-2期

关键词：

TOXIN DRUG-FREE; BOTULINUM NEUROTOXIN; 5-YEAR EXPERIENCE;

D O I：

10.1016/j.jns.2015.01.032

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：110 / 111

页数：2

共 13 条

[1] IncobotulinumtoxinA (Xeomin®) can produce antibody-induced therapy failure in a patient pretreated with abobotulinumtoxinA (Dysport®)
Dressler, Dirk
Saberi, Fereshte Adib
Bigalke, Hans
JOURNAL OF NEURAL TRANSMISSION, 2014, 121 (07) : 769 - 771
[2] IncobotulinumtoxinA (Xeomin®) can produce antibody-induced therapy failure in a patient pretreated with abobotulinumtoxinA (Dysport®)
Dirk Dressler
Fereshte Adib Saberi
Hans Bigalke
Journal of Neural Transmission, 2014, 121 : 769 - 771
[3] Secondary treatment failure in a patient with cervical dystonia after repetitive treatment with incobotulinumtoxinA and abobotulinumtoxinA
Jochim, A.
Castrop, F.
Jochim, B.
Haslinger, B.
MOVEMENT DISORDERS, 2014, 29 : S506 - S506
[4] Antibody-Induced Failure of Botulinum Toxin Therapy: Restart with Incobotulinumtoxina Offers a New Opportunity
Dressler, D.
Saberi, F. Adib
MOVEMENT DISORDERS, 2017, 32
[5] New formulation of Botox: complete antibody-induced treatment failure in cervical dystonia
Dressler, D.
Saberi, F. Adib
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2007, 78 (01): : 108 - 109
[6] Antibody-induced secondary treatment failure in a patient treated with botulinum toxin type A for glabellar frown lines
Stengel, Gabriele
Bee, Eva Kristina
CLINICAL INTERVENTIONS IN AGING, 2011, 6 : 281 - 284
[7] Clinical features of antibody-induced complete secondary failure of botulinum toxin therapy
Dressler, D
EUROPEAN NEUROLOGY, 2002, 48 (01) : 26 - 29
[8] Frequency and risk factors of antibody-induced secondary failure of botulinum neurotoxin therapy
Walter, Uwe
Muehlenhoff, Christopher
Benecke, Reiner
Dressler, Dirk
Mix, Eilhard
Alt, Janes
Wittstock, Matthias
Dudesek, Ales
Storch, Alexander
Kamm, Christoph
NEUROLOGY, 2020, 94 (20) : E2109 - E2120
[9] Antibody-induced failure of botulinum toxin type A therapy in a patient with masseteric hypertrophy
Lee, Soo-Keun
DERMATOLOGIC SURGERY, 2007, 33 : S105 - S110
[10] Botulinum toxin type B de novo, therapy of cervical dystonia: Frequency of antibody-induced therapy failure
Dressler, D
Bigalke, H
MOVEMENT DISORDERS, 2004, 19 : S105 - S105

← 1 2 →